Proteomic analysis of rat prefrontal cortex in three phases of morphine-induced conditioned place preference

Journal of Proteome Research

Volumn 6, Issue 6, 2007, Pages 2239-2247

  Yang, Liu ^a,b   Zhong, Sheng Sun ^c   Zhu, Yong Ping ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c INSTITUTE OF PSYCHOLOGY   (China)

Author keywords

Conditioned place preference (CPP); Morphine addiction; Neuroplasticity; Prefrontal cortex (PFC); Proteomics

Indexed keywords

CHAPERONE; CYTOSKELETON PROTEIN; MORPHINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; MASS SPECTROMETRY; NONHUMAN; PLACE PREFERENCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEOMICS; RAT; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CONDITIONING, CLASSICAL; MALE; MORPHINE; PREFRONTAL CORTEX; PROTEINS; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPSES;

RATTUS;

EID: 34250875149     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr060649o     Document Type: Article

References (44)

1. Robinson, T. E.; Kolb, B. Synapse 1999, 33, 160-162.
2. Greenough, W. T.; Withers, G. S.; Wallace, C. S. The biology of memory, Symposia Medica Hoechst; 1990; p 159-185.
3. Kolb, B.; Forgie, M.; Gibb, R.; Gorny G. et al. Neurosci. Biobehav. Rev. 1998, 22, 143-159.
4. Robinson, T. E.; Kolb, B. Neuropharmacology 2004, 47, Suppl 1: 33-46.
5. Miller, E.K.; Cohen, J. D. Annu. Rev. Neurosci. 2001, 24, 167-202.
6. Sheng, M. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 7058-7061.
7. Volkow, N. D; Fowler, J. S; Wang, G. J. J. Psychopharmacol. 1999, 13, 337-345.
8. Kilts, C. D; Schweitzer, J. B; Quinn, C. K; Gross, R. E.; et al. Arch. Gen. Psychiatry 2001, 58, 334-341.
9. Tzschentke, T. M. Prog. Neurobiol. 1998, 56, 613-672.
10. Parker, L. A.; Mcdonald, R. V. Pharmacol. Biochem. Behav. 2000, 66, 559-561.
11. Randall, C. K.; Kraemer, P. J.; Bardo, M. T. Pharmacol. Biochem. Behav. 1998, 60, 217-222.
12. Tzschentke, T. M. Prog. Neurobiol. 1998, 56, 613-672.
13. Hyman, S. E.; Malenka, R. C. Nat. Rev. Neurosci. 2001, 2, 695-703.
14. Shippenberg, T. S.; Heidbreder, C.; Lefevour, A. Eur. J. Pharmacol. 1996, 299, 33-39.
15. Zhou, L. F; Zhu, Y. P. J. Zhejiang. Univ. Sci. B 2006, 7, 107-113.
16. Paxinis, G.; Watson, C. The Rat Brain in Stereotaxic Coordinates, 4th ed; Academic Press: New York, 1998; p1-130.
17. Li, K. W.; Hornshaw, M. P.; Van Der Schors, R. C.; Watson, R.; et al. J. Biol. Chem. 2004, 279, 987-1002.
18. Bradford, M. M. Anal. Biochem. 1976, 72, 248-254.
19. Shevchenko, A.; Wilm, M.; Vorm, O.; Mann, M. Anal. Chem. 1996, 68, 850-858.
20. Yoshimura, Y.; Yamauchi, Y.; Shinkawa, T.; Taoka, M.; et al. J. Neurochem. 2004, 88, 759-768.
21. Naaby-Hansen, S.; Waterfield, M. D.; Cramer, R. Trends. Pharmacol. Sci. 2001, 22, 376-384.
22. Kim, S. Y.; Chudapongse, N.; Lee, S. M.; Levin, M. C.; et al. Brain. Res. Mol. Brain. Res. 2005, 133, 58-70.
23. Prokai, L.; Zharikova, A. D.; Stevens, S. M., Jr. J. Mass. Spectrom. 2005, 40, 169-75.
24. Li, K. W.; Jimenez, C. R.; van der Schors, R. C.; Hornshaw, M. P.; et al. Proteomics 2006, 6, 2003-2008.
25. Bierczynska-Krzysik, A.; Bonar, E.; Drabik, A.; Noga, M.; et al. Neurochem. Int. 2006, 49, 401-406.
26. Neasta, J.; Uttenweiler-Joseph, S.; Chaoui, K.; Monsarrat, B.; et al. Proteome Sci. 2006, 4(23), 1-10.
27. Iwazaki, T.; McGregor, I. S.; Matsumoto, I. Brain. Res. 2006, 1097, 19-25.
28. Freeman, W. M.; Brebner, K.; Amara, S. G.; Reed, M. S.; et al. Pharmacogenomics J. 2005, 5, 203-214.
29. Yeom, M.; Shim, I.; Lee, H. J.; Hahm, D. H. Biochem. Biophys. Res. Commun. 2005, 326, 321-328.
30. Loguinov, A. V; Anderson, L. M.; Crosby, G. J.; Yukhananov, R. Y. Physiol. Genomics 2001, 6, 169-181.
31. Gravel, M.; Gao, E.; Hervouet-Zeiber, C.; Parsons, V.; et al. J. Neurochem. 2000, 75, 1940-1950.
32. Cho, S. J.; Jung, J. S.; Shin, S. C.; Jin, I.; et al. Exp. Mol. Med. 2003, 35, 486-493.
33. Bifulco, M.; Laezza, C.; Stingo, S.; Wolff, J. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 1807-1812.
34. Malenka, R. C.; Bear, M. F. Neuron. 2004, 44, 5-21.
35. Lisman, J. E.; Zhabotinsky, A. M. Neuron. 2001, 31, 191-201.
36. Mao, L.; Yang, L.; Tang, Q.; Samdani, S. et al. J. Neurosci. 2005, 25, 2741-2752.
37. Szumlinski, K. K.; Dehoff, M. H.; Kang, S. H.; Frys, K. A. Neuron 2004, 43, 401-413.
38. Chilcote, T. J.; Siow, Y. L.; Schaeffer, E.; Greengard, P.; et al. J. Neurochem. 1994, 63, 1568-1571.
39. Greengard, P.; Valtorta, F.; Czernik, A. J.; Benfenati, F. Science 1993, 259, 780-785.
40. Rosahl, T. W.; Spillane, D.; Missler, M.; Herz, J.; et al. Nature 1995, 375, 488-493.
41. Stone, L. M.; Browning, M. D.; Finger, T. E. J. Neurosci. 1994, 14, 301-309.
42. Matus-Leibovitch, N.; Nevo, I.; Vogel, Z. Brain. Res. Mol. Brain. Res. 1997, 45, 301-316.
43. Garcia-Sevilla, J. A.; Ferrer-Alcon, M.; Martin, M.; Kieffer, B. L.; et al. Neuropharmacology 2004, 46, 519-530.
44. Chien, C. L.; Liu, T. C.; Ho, C. L.; Lu, K. S. J. Neurosci. Res. 2005, 80, 693-706.